Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of “engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs,
The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing ...
The Federal Trade Commission is suing the titans of the pharmacy benefit ... Express Scripts and Caremark—all ...
The Federal Trade Commission's administrative complaint follows an interim report from the agency regarding PBM practices.
The FTC report said the companies responsible for controlling spending on drugs were sometimes steering patients toward more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback